SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: S-8
Document Type: S-8
Date Filed: 2026-04-13
Accession Number: 0001213900-26-043054
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390026043054/ea0285991-s8_synergy.htm

Chunk 2 of 3
Word Count: 190
Character Count: 1206

Document Content:

to file the same with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto such attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as she/he might or could do in person, hereby ratifying and confirming all that such attorney-in-fact and agent, or her/his substitute or substitutes, may lawfully do or cause to be done by virtue hereof. Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated. Signature Title Dates /s/ Jack Ross Chief Executive Officer and Chairman (Principal Executive Officer) April 13, 2026 Jack Ross /s/ Jaime Fickett Chief Financial Officer (Principal Financial and Accounting Officer) April 13, 2026 Jaime Fickett

/s/ Alfred Baumeler President and Director April 13, 2026

Alfred Baumeler

/s/ J. Paul SoRelle Director April 13, 2026

J. Paul SoRelle

/s/ Nitin Kaushal Director April 13, 2026

Nitin Kaushal

/s/ Teresa Thompson Director April 13, 2026

Teresa Thompson